Adoption and validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic dysfunction-associated steatotic liver disease in low-resource South Asian settings.

<h4>Introduction</h4>Patients with significant liver fibrosis (SF) are likely to progress to advanced chronic liver disease (ACLD). Therefore, liver-directed therapy is indicated. The European Association for the Study of the Liver-2024 (EASL) recommends annual screening of patients with diabetes fo...

Повний опис

Збережено в:

Бібліографічні деталі
Автори:	Chamila Mettananda, Chamila Ranawaka, Thimira Egodage, Channaka Dantanarayana, Rumal Fernando, Lakmali Ranaweera, Dulani Kottahachchi, Shirom Siriwardhana, Arunasalam Pathmeswaran, Anuradha Dassanayake, Janaka de Silva
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Public Library of Science (PLoS) 2026-01-01
Серія:	PLoS ONE
Онлайн доступ:	https://doi.org/10.1371/journal.pone.0341364
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Adoption and validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic dysfunction-associated steatotic liver disease in low-resource South Asian settings.

Схожі ресурси